RRx-001:一种仿真的三重作用NLRP3抑制剂,Nrf2诱导剂和氧化超激素剂
Bryan Oronsky1, Lori Takahashi1, Richard Gordon2
1Drug Development, EpicentRx, Torrey Pines, CA, United States.
RRx-001是一种新型小分子,旨在预防头癌患者的化学辐射引起的严重口腔粘膜炎. 它的独特结构针对多个途径,为炎症组织提供治疗有效载荷.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 治疗头癌的化学辐射疗法经常导致严重的口腔粘膜炎 (SOM).
- 目前对SOM的治疗方法有限,需要新的治疗策略.
- RRx-001是一种小分子候选药物,用于SOM预防.
研究的目的:
- 审查RRx-001.1.的新设计.
- 讨论RRx-001.1.的体内亲氧化/亲炎和抗氧化/抗炎活动.
- 突出RRx-001作为SOM的向治疗的潜力.
主要方法:
- 审查RRx-001的分子结构和作用机制.
- 分析RRx-001的向部分 (NLRP3炎症酶和KEAP1抑制).
- 检查RRx-001的有效载荷释放机制 (低氧和还原激活的dnitroazetidine环).
主要成果:
- RRx-001作为一种仿真分子起作用,类似于抗体-药物联合体 (ADC),但作为一个小分子.
- 它针对NLRP3炎症酶和KEAP1,在缺氧,炎症的组织中释放氧化和基.
- 与ADC不同,RRx-001的小尺寸可以轻松穿透细胞膜和血脑屏障.
结论:
- RRx-001的设计使得针对SOM的目标交付和多机制行动成为可能.
- 它的活性是由组织氧化还原状态 (谷氨比率) 和氧化调节的.
- RRx-001代表了一种有前途的治疗药物,用于头癌中化学辐射诱导的SOM.
更多相关视频
08:32Application of Genetically Encoded Fluorescent Nitric Oxide (NO•) Probes, the geNOps, for Real-time Imaging of NO• Signals in Single Cells
Published on: March 16, 2017
14:02Optimizing the Genetic Incorporation of Chemical Probes into GPCRs for Photo-crosslinking Mapping and Bioorthogonal Chemistry in Live Mammalian Cells
Published on: April 9, 2018
相关概念视频
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Nitric Oxide Signaling Pathway
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
